HIV and multidrug resistance
Authors:
- Emilio A. EminiEEEmilio A. Emini
- Donald J. GrahamDGDonald J. Graham
- Leah GotlibLGLeah Gotlib
- Jon H. CondraJCJon H. Condra
- Vera W. ByrnesVBVera W. Byrnes
- 19 August 1993
- journal article
- Published by Springer Nature in Nature
- Vol. 364 (6439) , 679
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCRScience, 1993
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.Proceedings of the National Academy of Sciences, 1991
- Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse TranscriptaseScience, 1991
- Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitorsJournal of Virology, 1991
- Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990